Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

12/17/10 virtualtrials.com is back up!        

12/17/10 Insight offers new angle of attack on variety of brain tumors        

12/16/10 IBTA December 2010 E-News        

12/15/10 Florida Brain Tumor Association Brain Tumor Conference        

12/14/10 Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With a-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma [Editor's Note: This project was funded by the Musella Foundation]        

12/09/10 Musella Foundation end of year donation request!        

12/09/10 Musella Foundation end of year donation request!        

12/07/10 Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme        

12/04/10 New Drugs Target Recurrent Meningioma        

12/02/10 Device for Glioblastoma May Offer Advantage Over Chemo        

12/02/10 Baptist Hospital Patients To Receive First-Of-Kind Tumor Treatment [Low Grade Glioma Vaccine!]        

12/01/10 Bevacizumab Combinations Effective in Phase II Glioblastoma Trials        

11/30/10 Fuel Lines of Tumors Are New Target        

11/28/10 Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles        

11/22/10 Paclitaxel Poliglumex (OPAXIO®) Combined with Temozolomide and Radiotherapy Demonstrates High Response Rates with Encouraging Progression Free Survival in Malignant Brain Cancer        

11/21/10 Brain Tumors Grow Their Own Blood Supply        

11/20/10 Professor Zvi Ram Presents Phase III Recurrent Glioblastoma Survival and Quality of Life Data from the First Pivotal Study of the NovoTTF-100A at the 15th Annual Society for Neuro-Oncology (SNO) Scientific Meeting        

11/20/10 Celldex Therapeutics Reports Positive Results from Rindopepimut Phase 2 Brain Cancer Study at SNO 2010        

---

Displaying Stories 2990 to 3009 of 7806
Previous 20           Next 20